Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape

Description

This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion.

Important Dates:
Date of Release: December 21, 2023
Term of Approval/Date of Expiration: December 22, 2024

Learner Objectives:
Upon completion of this activity, you should be able to:

Describe safety, efficacy, and long-term CV outcomes data of bempedoic acid based on clinical trial data.

Identify patients that would benefit from bempedoic acid and how to integrate this into practice.

Develop a treatment plan for the statin intolerant patient including the use of bempedoic acid.

Acknowledgement
Educational grant support provided by: Esperion.

Faculty:
Erin D. Michos, MD, MHS, FACC

Summary


Availability:	On-Demand
	Expires on Dec 22, 2024


Cost:	FREE


Credit Offered:	No Credit Offered